BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20231422)

  • 1. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.
    Isnardi I; Ng YS; Menard L; Meyers G; Saadoun D; Srdanovic I; Samuels J; Berman J; Buckner JH; Cunningham-Rundles C; Meffre E
    Blood; 2010 Jun; 115(24):5026-36. PubMed ID: 20231422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
    Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
    Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity.
    Terrier B; Joly F; Vazquez T; Benech P; Rosenzwajg M; Carpentier W; Garrido M; Ghillani-Dalbin P; Klatzmann D; Cacoub P; Saadoun D
    J Immunol; 2011 Dec; 187(12):6550-63. PubMed ID: 22084433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM.
    Quách TD; Manjarrez-Orduño N; Adlowitz DG; Silver L; Yang H; Wei C; Milner EC; Sanz I
    J Immunol; 2011 Apr; 186(8):4640-8. PubMed ID: 21398610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
    J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antigen Presenting Potential of CD21
    Reincke ME; Payne KJ; Harder I; Strohmeier V; Voll RE; Warnatz K; Keller B
    Front Immunol; 2020; 11():535784. PubMed ID: 33193306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
    Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ
    Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: Complement (C3d)-linked antigens break B cell anergy.
    Lyubchenko T; Dal Porto JM; Holers VM; Cambier JC
    J Immunol; 2007 Sep; 179(5):2695-9. PubMed ID: 17709481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
    Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
    Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21(low) B cells.
    Mitrevski M; Marrapodi R; Camponeschi A; Lazzeri C; Todi L; Quinti I; Fiorilli M; Visentini M
    Immunol Res; 2014 Dec; 60(2-3):330-8. PubMed ID: 25407649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low percentages of regulatory T cells in common variable immunodeficiency (CVID) patients with autoimmune diseases and its association with increased numbers of CD4+CD45RO+ T and CD21
    López-Herrera G; Segura-Méndez NH; O'Farril-Romanillos P; Nuñez-Nuñez ME; Zarate-Hernández MC; Mogica-Martínez D; Yamazaki-Nakashimada MA; Staines-Boone AT; Santos-Argumedo L; Berrón-Ruiz L
    Allergol Immunopathol (Madr); 2019; 47(5):457-466. PubMed ID: 31103252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High SYK Expression Drives Constitutive Activation of CD21
    Keller B; Stumpf I; Strohmeier V; Usadel S; Verhoeyen E; Eibel H; Warnatz K
    J Immunol; 2017 Jun; 198(11):4285-4292. PubMed ID: 28468967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD23/CD21 and CD40/CD40 ligand in vernal keratoconjunctivitis.
    Abu El-Asrar AM; Fatani RA; Missotten L; Geboes K
    Eye (Lond); 2001 Apr; 15(Pt 2):217-24. PubMed ID: 11339595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.
    Rakhmanov M; Keller B; Gutenberger S; Foerster C; Hoenig M; Driessen G; van der Burg M; van Dongen JJ; Wiech E; Visentini M; Quinti I; Prasse A; Voelxen N; Salzer U; Goldacker S; Fisch P; Eibel H; Schwarz K; Peter HH; Warnatz K
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13451-6. PubMed ID: 19666505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncontrolled CD21
    Masle-Farquhar E; Peters TJ; Miosge LA; Parish IA; Weigel C; Oakes CC; Reed JH; Goodnow CC
    Cell Rep; 2022 Jan; 38(3):110259. PubMed ID: 35045301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
    Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
    J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21
    Glauzy S; Boccitto M; Bannock JM; Delmotte FR; Saadoun D; Cacoub P; Ice JA; Sivils KL; James JA; Wolin SL; Meffre E
    Arthritis Rheumatol; 2018 Feb; 70(2):298-307. PubMed ID: 29073352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.